Sangamo Therapeutics (NasdaqCM:SGMO) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsCassie Yuan - Biotechnology Equity Research AssociateJames Heaney - Equity Research SVPLouise Wilkie - Head of Investor Relations and Corporate CommunicationsLuis Santos - Senior Equity Research AssociateNathalie Dubois-Stringfellow - Chief Development OfficerSandy Macrae - CEOOperatorGood afternoon, and welcome to the Sangamo Therapeutics fourth quarter and full year 2025 teleconference call. Please be ...

Sangamo Therapeutics (NasdaqCM:SGMO) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Speaker3Good afternoon, and welcome to the Sangamo Therapeutics fourth quarter and full year 2025 teleconference call. Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker today, Louise Wilkie, Head of Investor Relations and Corporate Communications. Please go ahead.Speaker0Thank you. Good afternoon, everyone. Thank you for joining us on the call today. O ...